About APEN

San Diego-basedLpath, Inc.(LPTN) is the category leader in lipid-targeted therapeutics. The company's ImmuneY2 drug-discovery engine has the unique ability to generate therapeutic antibodies that bind and inhibit bioactive lipids that contribute to disease. The company has developed four drug candidates, has advanced the first two to mid-stage trials and built evidence to support its approach of targeting bioactive lipids to treat a wide range of diseases.
Primary Exchange: NASDAQ
SIC Surgical & Medical Instruments & Apparatus
NAICS Surgical and Medical Instrument Manufacturing

APEN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VTI Vanguard Total Stock Market ETF 108.6 B 1.086E+11 3,570 3570 0.0% 0 114 K 114095
VXF Vanguard Extended Market ETF 6.5 B 6.5E+09 3,237 3237 0.0% 1E-05 48 K 47620
ITOT iShares Core S&P Total U.S. Stock Market ETF 21.0 B 2.09757E+10 3,548 3548 0.0% 0 264 264
IWC iShares Microcap ETF 850.6 M 8.50572E+08 1,426 1426 0.01% 0.0001 91 K 91214